Etika a právo v psychiatrii

MUDr. Tomáš Lajkep Ph.D, Mgr. Ing. Lukáš Prudil Ph.D

Psychiatr. pro Praxi, 2006; 6: 302-303  

Medicínou obcházejí strašidla

prof. MUDr. Vladimír Mihál CSc

Psychiatr. pro Praxi, 2006; 6: 263  

DOSING OF ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

MUDr. Sylva Racková, MUDr. Luboš Janů Ph.D

Psychiatr. pro Praxi, 2006; 6: 268-271  

Schizophrenia is a serious disorder with the beginning especially in the adolescent and early adult ages. There is a high percentage of chronic course in this disorder. Long-term antipsychotic medication is necessary in the treatment, first in the treatment of acute state and then in the profylaxis of relapses. During the treatment of antipsychotics is the risk of development of adverse events, which has an influence on acute and long-term compliance. One of the possibilities of prevention of development of adverse events is an adequate dosage of this medication. The survey of factors, which are necessary to pay attention for choosing of the dose of...

Antiepileptic Drug and Pregnancy

doc. MUDr. Robert Kuba Ph.D

Psychiatr. pro Praxi, 2006; 6: 272-275  

The topic of epilepsy and pregnancy keep to be actual topic covering neurology, psychiatry and other specialties, where antiepileptic medications are used. This review article provides basic information referring to practical use of antiepileptics in fertile age and describes specific problems of individual periods in relation to pregnancy.

The Introduction to the Biological Treatment of Resistant Depression

MUDr. Martin Bareš, MUDr. Miloslav Kopeček Ph.D

Psychiatr. pro Praxi, 2006; 6: 276-280  

Depressive disorder is relatively common disease in population. Lifetime prevalence of major depression is 5–12% in men and 9–26% in women. Approximately 30% of patients treated with first antidepressants achieve remission. The resistant depression is commonly defined as depression which was unsuccessfully treated by 2 antidepressants from various groups. The authors comment possibilities of resistant depression treatment (change of antidepressants, augmentation and combination of antidepressants, repetitive transcranial magnetic stimulation, electroconvulsive therapy etc.).

Detoxification in the addiction to methamphetamine

MUDr. Jitka Svobodová Ph.D, Ph.D: Michael Václavík

Psychiatr. pro Praxi, 2006; 6: 282-284  

Methamphetamine is a stimulating drug with an indirect effect caused by the influencing of the transport mechanisms of dopamine, noradrenalin and serotonin. Neuro-adaptation mechanisms participate in the development of addiction with a predominant mental component. Abstinent syndrome during withdrawal is characterized by depression, fatigue and a lack of energy. In the next phase a strong desire for the drug appears. Although mental complications are gradually decreasing, they can last for weeks or even months. Paranoid syndrome and hallucination can be as a result of using the drug and mostly disappear spontaneously, unlike the symptoms of schizophrenic...

Depression with anxiety and sleep disturbances

MUDr. Jiřina Kosová

Psychiatr. pro Praxi, 2006; 6: 285-287  

Comorbidity of depressive and anxiety disorders is very frequent mainly in the primary care, where it is more the rule than the extinction. Historically, the classification of anxiety disorders and depression has varied as function of how the medical profession has viewed the association between the two. Comorbid depressive and anxiety disorders were predictive of more persistent course with severe symptoms, these patients have more hospitalizations, and they were more likely to report suicide attempts. Sleep disturbances are an integral part of depressive disorder and many anxiety disorders, and it is reported by more than 90 % of patients. Early...

Compulsory treatment in manic episode of affective disorder

MUDr. Pavel Baudiš CSc

Psychiatr. pro Praxi, 2006; 6: 289-290  

Theoretical, legislative and practical rules and advices are given for the successfully and dignified contact with manic patients and for the compulsory admission into psychiatric facilities.

Ovlivnění sluchových halucinací aplikací repetitivní transkraniální magnetické stimulace na oblast temporoparietálního kortexu

MUDr. Simona Skotáková, MUDr. Radovan Přikryl Ph.D, MUDr. Tomáš Kašpárek Ph.D, MUDr. Libor Ustohal, Mgr. Petra Navrátilová, MUDr. Jana Tomanová

Psychiatr. pro Praxi, 2006; 6: 295-296  

Atypický obraz neuroleptického maligního syndromu

MUDr. Martin Hýža, MUDr. Vlasta Hanušková

Psychiatr. pro Praxi, 2006; 6: 297-299  

Kazuistika pacienta s bipolární afektivní poruchou

MUDr. Libor Ustohal, MUDr. Vítězslav Pálenský

Psychiatr. pro Praxi, 2006; 6: 300-301  

TREATMENT OF DEMENTIA OF THE ALZHEIMER TYPE BY MEMANTINE

MUDr. Elena Žigová

Psychiatr. pro Praxi, 2006; 6

The article treats the subject of basic pathogenetic factors of the development of dementia of the Alzheimer type (DAT), of current knowledge and possibilities of pharmacological influence of the dynamics and effects of the neurodegenerative changes in the brain and of cellular death. The focus is on the role of glutamatergal transmission in the pathogenesis of DAT and the possibilities of therapeutic influence of memanthin. The results of clinical studies of effectiveness of treatment by memanthin and the results of post marketing clinical study ELPACH in Slovakia are cited. The practical recommendations for the treatment by memanthin are summarized...

Konference ambulantních psychiatrů, Olomouc (14.-15. 9. 2006)

Mgr. Iva Daňková

Psychiatr. pro Praxi, 2006; 6: 304  

Zemské ústavy pro choromyslné v českém království

MUDr. Emanuel Doněk, MUDr. Jana Doňková, Ing. Radim Beneš

Psychiatr. pro Praxi, 2006; 6: 305-306